NDT Pharmaceuticals Enhances E-Commerce and Plans Marketing Growth

3/3/2026, 6:01:17 AM

ATHENS, Ga. — March 3, 2026 — Leads & Copy — NDT Pharmaceuticals, Inc. (OTC: NDTP) is strengthening its e-commerce ecosystem through its subsidiary, Good Salt Life, Inc., by leveraging its presence on digital marketplaces like Amazon, Chewy.com, and Walmart.

According to management, the final quarter of 2025 was a turning point for NDT’s retail infrastructure. NDT Pharmaceuticals strategically optimized its digital storefront on Walmart.com, positioning Good Salt Life’s HOCl-based product lines within reach of American consumers. The company anticipates this digital marketing expansion will create brand awareness throughout 2026.

CEO of NDT Pharmaceuticals, Zach O’Shea, said the company’s presence on Walmart, Amazon and Chewy, completes a retail triangle for the company. O’Shea viewed the close of Q4 as a period of strategic energy that has carried into the first two months of 2026. As consumers prioritize nontoxic solutions for their homes and pets, NDT Pharmaceuticals has taken steps to position its brand where consumers are looking to discover new products.

NDT Pharmaceuticals is also scaling its internal marketing and digital growth division to amplify its market presence. The company anticipates that investing in human capital could advance its data analytics, customer acquisition cost (CAC) optimization, and cross-platform advertising expenditure. NDT believes this infusion of talent could capture market share, enhance brand storytelling, and optimize conversion.

Market share will be captured through scaling digital ad spending to increase market share in the disinfectant and pet-care categories, the company said. Brand storytelling will communicate the science of NDT’s technology to a wider audience, and conversion will be optimized to refine the “click-to-cart” journey across Walmart, Chewy and Amazon to drive higher lifetime value.

O’Shea said the company is optimistic about the coming months, and by expanding the marketing team, NDT is putting the necessary “engine” behind its products. He believes this increased operational capacity will increase sales volume and deepen market penetration throughout 2026.

NDT Pharmaceuticals Inc. is a publicly traded company dedicated to advancing consumer health and wellness solutions. Through its wholly owned subsidiary, Good Salt Life Inc., the company invests in sustainable, science-driven brands that protect people, pets, and the planet. Good Salt Life is a vertically integrated biosafety company focused on designing and deploying eco-friendly infection-control ecosystems, and their Clean Republic brand offers hospital-grade efficacy with a focus on vitality and safety.

Source: NDT Pharmaceuticals, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.